1 June 2026

Clinical Obesity Pharmaceuticals

What dose works best for weight maintenance?

25 May 2026

Cancer Obesity

What links obesity and cancer?

18 May 2026

Cardiovascular Clinical Guidelines Obesity

Finally, national consensus on obesity and CVD

18 May 2026

IBD Obesity Research

IBD more prevalent in obese populations

4 May 2026

Cardiovascular Diabetes Obesity Research

A potential new way to target excess glycogen stores

2 April 2026

Obesity Political

Don’t blow all the obesity cash on GLP-1s

19 March 2026

Clinical Obesity Pregnancy

It’s not just mum’s BMI that impacts a child’s risk of MASLD

15 January 2026

Obesity Osteoarthritis Pain Pharmaceuticals

There’s a new weight loss drug in town

13 January 2026

Obesity Public Health

Stopping weight-loss drugs triggers rapid rebound

3 December 2025

Guidelines Obesity Pharmaceuticals

WHO backs GLP-1s for obesity, but can Australia deliver?

2 December 2025

Clinical Obesity

Bruxism and temporomandibular disorders in GP

24 November 2025

Clinical Obesity Sleep

GLP-1s for sleep apnoea – are they a game-changer?

24 November 2025

Obesity Pharmaceuticals Surgery

GLP-1s could help avoid follow-up bariatric surgery

4 November 2025

Diabetes Obesity Pharmaceuticals

UK regulators smash illegal weight-loss drug factory

16 October 2025

Diabetes Obesity

GLP-1 RAs linked to rising rates of hair loss

14 October 2025

Obesity Pharmaceuticals

If not BMI for GLP-1s, then what?